Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Kenneth Buetow; George Komatsoulis; Karin Fredrikson & Others

Premium

Arizona State University said this week that Kenneth Buetow will take on the role of director of computational sciences and informatics in the university's newly launched Complex Adaptive Systems Initiative, effective March 5.

He will also be a full professor in the school of life sciences in ASU’s College of Liberal Arts and Sciences.

Buetow was previously director of the Center for Biomedical Informatics and Information Technology at the National Cancer Institute. George Komatsoulis, NCI CBIIT's deputy director, has been appointed interim director.

Buetow obtained a doctorate and a master’s degree in human genetics from the University of Pittsburgh and an undergraduate degree in biology from Indiana University.


Biomatters has tapped Karin Fredrikson to serve as vice president of its US operations in Newark, NJ, and San Francisco effective March 5.

Prior to joining Biomatters, Fredrikson was the director of business development for Roche’s 454 Life Sciences.


Simulations Plus announced this week that Richard Weiss is retiring from its board of directors.

David Ralph, a professor of marketing at Pepperdine University, has been elected to fill the vacancy left by Weiss, which includes participation in the board’s audit, compensation, and nominating committees.
Ralph received his doctorate from the University of Southern California following Bachelor’s and Master’s degrees in business administration and management from Pepperdine University.


IBM has selected Lynda Chin to serve on the Watson Healthcare Advisory Board, which will focus on medical industry trends, clinical imperatives, regulatory considerations, privacy concerns, and patient and clinician expectations around the Watson technology and how it can be incorporated into clinician workflows.

Chin is a professor in the department of genomic medicine at the University of Texas MD Anderson Cancer Center. She is also involved in the Cancer Genome Atlas and the International Cancer Genome Consortium.


The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.